Provide strategic and technical guidance to CMC team members on project teams on process development, product analytics, formulation and fill, final manufacturing process and facility design and needs, and quality control thereof, investigational product supply and stability, as well as in vivo and in vitro safety and toxicity testing performed before and during the clinical development to demonstrate non-clinical safety and tolerability of candidate vaccine products. The Global Head of CMC is a member of the CVIA leadership team (CVIA LT) and is responsible for CVIA-wide business plan creation and implementation, change initiative leadership, talent management, and proactive partnership in developing comprehensive cross-disciplinary tactics and enabling exceptional execution through cross-functional collaboration.